Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Timothy Garrington

Concepts (315)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Central Nervous System Neoplasms
2
2024
149
0.730
Why?
Rhabdomyosarcoma
1
2019
64
0.590
Why?
Sarcoma, Ewing
3
2025
89
0.580
Why?
MAP Kinase Kinase Kinases
6
2004
71
0.540
Why?
Mitogen-Activated Protein Kinases
8
2004
312
0.420
Why?
Hodgkin Disease
2
2016
134
0.390
Why?
Kidney Neoplasms
3
2021
350
0.340
Why?
Neuroblastoma
3
2017
154
0.340
Why?
Neoplasms
6
2025
2470
0.320
Why?
Mitogen-Activated Protein Kinase Kinases
4
2004
131
0.310
Why?
Beckwith-Wiedemann Syndrome
1
2008
6
0.310
Why?
Adrenal Gland Neoplasms
2
2014
84
0.310
Why?
Fluorodeoxyglucose F18
1
2009
129
0.310
Why?
Asparaginase
2
1998
29
0.300
Why?
Neoplasms, Multiple Primary
1
2008
55
0.300
Why?
Positron-Emission Tomography
1
2009
288
0.290
Why?
JNK Mitogen-Activated Protein Kinases
5
2004
161
0.290
Why?
MAP Kinase Kinase Kinase 1
3
2005
19
0.290
Why?
Adrenal Cortex Neoplasms
1
2008
60
0.290
Why?
Histiocytosis, Langerhans-Cell
2
2020
37
0.280
Why?
Pancreatitis
2
1998
129
0.270
Why?
Child
23
2025
20883
0.250
Why?
MAP Kinase Kinase Kinase 2
7
2012
12
0.250
Why?
Mast Cells
3
2003
142
0.250
Why?
Adaptor Proteins, Signal Transducing
4
2003
399
0.240
Why?
Testicular Neoplasms
2
2017
104
0.240
Why?
Child, Preschool
17
2021
10517
0.240
Why?
Genetic Heterogeneity
1
2025
58
0.240
Why?
Clonal Evolution
1
2025
39
0.230
Why?
Appointments and Schedules
1
2025
84
0.230
Why?
Medical Errors
1
2025
104
0.220
Why?
Fibroblast Growth Factor 2
1
2004
85
0.220
Why?
Catheterization, Central Venous
1
2025
103
0.210
Why?
Neoplasms, Germ Cell and Embryonal
2
2016
69
0.210
Why?
Central Nervous System Diseases
1
2024
68
0.210
Why?
MAP Kinase Signaling System
3
2008
312
0.200
Why?
Lung Neoplasms
2
2021
2344
0.200
Why?
Neoplasms, Second Primary
1
2024
106
0.200
Why?
Bone Neoplasms
1
2025
231
0.200
Why?
Single-Cell Analysis
1
2025
277
0.200
Why?
Parental Leave
1
2022
24
0.200
Why?
Adolescent
18
2025
20393
0.200
Why?
Anemia
1
2023
160
0.190
Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
1999
181
0.190
Why?
Sarcoma
2
2015
176
0.180
Why?
Thrombocytopenia
1
2023
186
0.180
Why?
Tomography, X-Ray Computed
2
2021
2535
0.180
Why?
Pulmonary Blastoma
1
2021
8
0.180
Why?
RNA, Neoplasm
1
2021
88
0.180
Why?
Circulating Tumor DNA
1
2021
28
0.180
Why?
Biomarkers, Tumor
2
2025
1181
0.180
Why?
Stem Cell Factor
1
2000
15
0.180
Why?
Pituitary Diseases
1
2020
21
0.180
Why?
Ribonuclease III
1
2021
37
0.180
Why?
Receptors, IgE
1
2000
44
0.170
Why?
Sertoli-Leydig Cell Tumor
1
2020
8
0.170
Why?
Cholestasis
1
2023
232
0.170
Why?
Fibroblasts
3
2005
948
0.170
Why?
Rhabdomyosarcoma, Embryonal
1
2020
20
0.170
Why?
DEAD-box RNA Helicases
1
2021
66
0.170
Why?
Pituitary Gland
1
2020
148
0.170
Why?
Lymphohistiocytosis, Hemophagocytic
1
2020
29
0.170
Why?
Survival Rate
3
2019
1877
0.160
Why?
Fellowships and Scholarships
1
2022
273
0.160
Why?
Humans
37
2025
129650
0.150
Why?
Disease-Free Survival
2
2019
648
0.150
Why?
Proto-Oncogene Proteins B-raf
1
2020
212
0.150
Why?
Infant
11
2020
9024
0.150
Why?
Polycystic Kidney Diseases
1
2019
68
0.150
Why?
Octreotide
1
1998
27
0.140
Why?
Female
22
2025
68776
0.140
Why?
Biopsy, Large-Core Needle
1
2017
13
0.140
Why?
Antibodies, Neutralizing
1
2020
265
0.140
Why?
Abdominal Neoplasms
1
2017
34
0.140
Why?
Cancer Survivors
1
2022
263
0.140
Why?
Cytodiagnosis
1
2017
32
0.130
Why?
Seminoma
1
2017
17
0.130
Why?
Frozen Sections
1
2017
26
0.130
Why?
Wilms Tumor
1
2018
77
0.130
Why?
Quality Improvement
1
2025
1103
0.130
Why?
Male
21
2025
63681
0.130
Why?
Interferon-gamma
1
2020
770
0.130
Why?
Cytokines
2
2004
2017
0.130
Why?
Tumor Necrosis Factor-alpha
4
2003
1198
0.130
Why?
Protein Processing, Post-Translational
1
1999
455
0.130
Why?
Enzyme Activation
6
2004
811
0.130
Why?
Saccharomyces cerevisiae Proteins
1
1999
385
0.120
Why?
Health Planning
1
2015
47
0.120
Why?
Ovarian Neoplasms
1
2020
490
0.120
Why?
Mediastinal Neoplasms
1
2014
38
0.110
Why?
Thoracoscopy
1
2014
52
0.110
Why?
Transcription Factor AP-1
2
2005
85
0.110
Why?
Genetic Predisposition to Disease
2
2021
2282
0.110
Why?
Transition to Adult Care
1
2015
79
0.110
Why?
Disease Management
2
2015
589
0.110
Why?
Xanthogranuloma, Juvenile
1
2013
5
0.110
Why?
Arabinonucleosides
1
2013
8
0.110
Why?
Carrier Proteins
4
2003
743
0.110
Why?
Adenine Nucleotides
1
2013
22
0.110
Why?
Biopsy
1
2017
1097
0.110
Why?
Histiocytosis, Sinus
1
2013
7
0.110
Why?
Retrospective Studies
7
2024
14518
0.110
Why?
Ambulatory Care Facilities
1
2015
228
0.110
Why?
Antibodies, Monoclonal
1
2020
1367
0.100
Why?
Antimetabolites, Antineoplastic
1
2013
91
0.100
Why?
Salvage Therapy
1
2013
134
0.100
Why?
Anesthesia
1
2014
134
0.100
Why?
Heart Diseases
1
2016
350
0.100
Why?
Prognosis
5
2025
3794
0.100
Why?
Prevalence
1
2019
2564
0.100
Why?
Hypertrophy, Right Ventricular
1
2012
145
0.100
Why?
Diagnostic Imaging
1
2014
334
0.090
Why?
Gene Expression Regulation
4
2012
2548
0.090
Why?
Receptors, Tumor Necrosis Factor
2
2002
161
0.090
Why?
Signal Transduction
3
2004
4925
0.090
Why?
Program Development
2
2015
357
0.090
Why?
Ventricular Remodeling
1
2012
255
0.090
Why?
Stem Cells
2
2008
577
0.090
Why?
Pediatrics
2
2008
1052
0.080
Why?
Laparoscopy
1
2014
451
0.080
Why?
Subtraction Technique
1
2009
23
0.080
Why?
Primary Health Care
2
2022
1680
0.080
Why?
Radiopharmaceuticals
1
2009
168
0.080
Why?
Potassium Channels, Voltage-Gated
1
2008
50
0.070
Why?
Myocytes, Cardiac
1
2012
499
0.070
Why?
Polymerase Chain Reaction
2
2021
1038
0.070
Why?
Heart Ventricles
1
2012
781
0.070
Why?
Antineoplastic Agents
1
1998
2061
0.070
Why?
Infant, Newborn
4
2023
5762
0.070
Why?
Liver Neoplasms
1
2012
640
0.070
Why?
Embryo, Mammalian
2
2005
226
0.070
Why?
Mitogen-Activated Protein Kinase 7
4
2012
21
0.060
Why?
Risk Assessment
1
2015
3240
0.060
Why?
Adult
6
2019
35576
0.060
Why?
Leukemia
1
2008
230
0.060
Why?
Young Adult
6
2018
12426
0.060
Why?
Age Factors
3
2018
3144
0.060
Why?
Near Miss, Healthcare
1
2025
10
0.060
Why?
Hypoxia
1
2012
1084
0.060
Why?
Epidermal Growth Factor
2
2003
171
0.060
Why?
Cell Line
5
2003
2781
0.060
Why?
Acute Disease
2
1998
980
0.060
Why?
Education, Medical, Undergraduate
1
2007
176
0.060
Why?
Transcription Factors
2
2021
1651
0.060
Why?
Proto-Oncogene Proteins c-jun
1
2005
52
0.060
Why?
Killer Cells, Natural
1
2008
427
0.060
Why?
SEER Program
2
2016
206
0.060
Why?
Neoplastic Cells, Circulating
1
2025
71
0.060
Why?
Cord Blood Stem Cell Transplantation
1
2005
99
0.060
Why?
Phosphorylation
3
2012
1713
0.060
Why?
MAP Kinase Kinase 4
1
2004
28
0.060
Why?
Genes, jun
1
2003
9
0.050
Why?
Apoptosis
3
2002
2503
0.050
Why?
Blotting, Western
2
2004
1205
0.050
Why?
Neoplasm Metastasis
2
2018
610
0.050
Why?
Survival Analysis
2
2018
1274
0.050
Why?
Myogenic Regulatory Factors
1
2003
56
0.050
Why?
DNA Methylation
1
2008
607
0.050
Why?
Fluorescent Antibody Technique
1
2004
376
0.050
Why?
Tissue Donors
1
2005
391
0.050
Why?
Macromolecular Substances
2
2003
213
0.050
Why?
Sequence Analysis, RNA
1
2025
429
0.050
Why?
Promoter Regions, Genetic
3
2005
1207
0.050
Why?
Animals
9
2012
35361
0.050
Why?
Mice
6
2012
16937
0.050
Why?
Mice, Knockout
2
2012
2871
0.050
Why?
src-Family Kinases
1
2003
96
0.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2005
278
0.050
Why?
Recurrence
3
2013
1007
0.050
Why?
Survivors
2
2016
464
0.050
Why?
Cell Differentiation
2
2000
1902
0.050
Why?
Academic Medical Centers
1
2025
481
0.050
Why?
Databases, Factual
2
2018
1269
0.050
Why?
Central Nervous System
1
2024
257
0.050
Why?
Enzyme-Linked Immunosorbent Assay
1
2004
833
0.050
Why?
Cells, Cultured
3
2005
4083
0.050
Why?
Survivorship
1
2022
48
0.050
Why?
Protein-Tyrosine Kinases
2
2008
432
0.050
Why?
Mutation
3
2020
3717
0.050
Why?
Proto-Oncogene Protein c-fli-1
1
2021
24
0.050
Why?
RNA-Binding Protein EWS
1
2021
24
0.050
Why?
Tumor Microenvironment
1
2025
634
0.040
Why?
Curriculum
1
2007
917
0.040
Why?
Kidney Diseases, Cystic
1
2021
21
0.040
Why?
Hypertension, Pulmonary
1
2012
1894
0.040
Why?
Transcription, Genetic
2
2005
1418
0.040
Why?
Receptor Aggregation
1
2000
10
0.040
Why?
Translocation, Genetic
1
2021
97
0.040
Why?
Pneumothorax
1
2021
38
0.040
Why?
Reoviridae
1
2000
37
0.040
Why?
Chemokine CXCL9
1
2020
26
0.040
Why?
Germ-Line Mutation
1
2021
140
0.040
Why?
Syndrome
1
2021
341
0.040
Why?
Surveys and Questionnaires
2
2022
5406
0.040
Why?
Mutagenesis, Site-Directed
1
2000
361
0.040
Why?
p38 Mitogen-Activated Protein Kinases
1
2000
274
0.040
Why?
Mating Factor
1
1999
3
0.040
Why?
Follow-Up Studies
2
2020
4897
0.040
Why?
Oncogene Proteins, Fusion
1
2021
201
0.040
Why?
Cell Compartmentation
1
1999
52
0.040
Why?
Receptors, Growth Factor
1
1999
55
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2025
1356
0.040
Why?
Growth Substances
1
1999
152
0.040
Why?
Insect Proteins
1
1999
35
0.040
Why?
Proto-Oncogene Proteins
1
2002
638
0.040
Why?
TRPP Cation Channels
1
2019
79
0.040
Why?
Transcriptional Activation
1
2000
366
0.040
Why?
Education, Medical, Graduate
1
2022
438
0.040
Why?
Fungal Proteins
1
1999
130
0.040
Why?
Age of Onset
1
2020
496
0.040
Why?
Gene Expression Profiling
1
2025
1706
0.040
Why?
MAP Kinase Kinase 5
3
2003
4
0.040
Why?
Chronic Disease
2
2015
1720
0.040
Why?
Cytoskeleton
1
1999
183
0.040
Why?
Membrane Glycoproteins
1
2000
474
0.040
Why?
Dexamethasone
1
2020
346
0.040
Why?
Kaplan-Meier Estimate
1
2020
857
0.040
Why?
United States
3
2022
13903
0.030
Why?
DNA-Binding Proteins
1
2005
1443
0.030
Why?
Combined Modality Therapy
1
2020
1206
0.030
Why?
Mammals
1
1999
271
0.030
Why?
Incidence
1
2024
2644
0.030
Why?
Drosophila melanogaster
1
1999
215
0.030
Why?
Hepatoblastoma
1
2017
41
0.030
Why?
Drug Therapy, Combination
1
2020
1040
0.030
Why?
Receptors, Cell Surface
1
2019
380
0.030
Why?
Intraoperative Period
1
2017
53
0.030
Why?
Microtubules
1
1999
263
0.030
Why?
Anti-Inflammatory Agents
1
2020
480
0.030
Why?
Teratoma
1
2017
105
0.030
Why?
Stress, Physiological
1
1999
413
0.030
Why?
Epidemiological Monitoring
1
2016
50
0.030
Why?
Caenorhabditis elegans
1
1999
291
0.030
Why?
Time Factors
2
2018
6556
0.030
Why?
Saccharomyces cerevisiae
1
1999
532
0.030
Why?
Hematopoietic Stem Cell Transplantation
1
2020
573
0.030
Why?
Neurilemmoma
1
2014
23
0.030
Why?
Organizational Innovation
1
2015
139
0.030
Why?
Interdisciplinary Communication
1
2015
186
0.030
Why?
Parents
1
2022
1309
0.030
Why?
Peptides
1
1999
925
0.030
Why?
Reproducibility of Results
1
2021
3083
0.030
Why?
Lymphoma
1
2014
196
0.030
Why?
Neoplasm Staging
1
2017
1295
0.030
Why?
RNA, Messenger
1
2000
2708
0.030
Why?
Logistic Models
1
2018
1988
0.030
Why?
MAP Kinase Kinase 7
2
2003
7
0.030
Why?
T-Lymphocytes
1
2000
1928
0.020
Why?
Analysis of Variance
1
2015
1288
0.020
Why?
Two-Hybrid System Techniques
2
2003
56
0.020
Why?
Colorado
2
2015
4421
0.020
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
2
2002
29
0.020
Why?
fas Receptor
2
2002
95
0.020
Why?
Program Evaluation
1
2015
875
0.020
Why?
Caspases
2
2002
245
0.020
Why?
Treatment Outcome
2
2020
10230
0.020
Why?
Aged
2
2022
22103
0.020
Why?
Transfection
2
2003
911
0.020
Why?
Inflammation Mediators
1
2012
505
0.020
Why?
Ultrasonography
1
2012
716
0.020
Why?
Receptor, IGF Type 1
1
2008
65
0.020
Why?
Chemistry, Pharmaceutical
1
2008
107
0.020
Why?
Practice Patterns, Physicians'
1
2017
1266
0.020
Why?
Drug Design
1
2008
156
0.020
Why?
Bone Marrow Transplantation
1
2008
274
0.020
Why?
Pancreatic Neoplasms
1
2014
882
0.020
Why?
Schools, Medical
1
2007
132
0.020
Why?
Clinical Clerkship
1
2007
95
0.020
Why?
Medical Oncology
1
2008
272
0.020
Why?
Vascular Endothelial Growth Factor A
1
2008
530
0.020
Why?
Histocompatibility Testing
1
2005
120
0.020
Why?
Protein Binding
2
2003
2121
0.020
Why?
Prospective Studies
1
2017
7133
0.020
Why?
Middle Aged
2
2017
31154
0.020
Why?
Fos-Related Antigen-2
1
2005
1
0.020
Why?
Oligonucleotide Probes
1
2005
50
0.010
Why?
Urokinase-Type Plasminogen Activator
1
2005
29
0.010
Why?
Tetradecanoylphorbol Acetate
1
2005
149
0.010
Why?
Aged, 80 and over
1
2016
7086
0.010
Why?
Dimerization
1
2005
192
0.010
Why?
Faculty, Medical
1
2007
264
0.010
Why?
Transplantation, Homologous
1
2005
401
0.010
Why?
Flow Cytometry
1
2008
1156
0.010
Why?
Clinical Trials as Topic
1
2008
1004
0.010
Why?
MEF2 Transcription Factors
1
2003
61
0.010
Why?
Graft vs Host Disease
1
2005
241
0.010
Why?
Mink
1
2003
12
0.010
Why?
Osmolar Concentration
1
2003
166
0.010
Why?
Amino Acid Motifs
1
2003
213
0.010
Why?
Disease Models, Animal
1
2012
4063
0.010
Why?
Multivariate Analysis
1
2005
1502
0.010
Why?
Cell Nucleus
1
2005
582
0.010
Why?
Caspase 3
1
2002
245
0.010
Why?
Models, Biological
1
2008
1722
0.010
Why?
Base Sequence
1
2005
2142
0.010
Why?
MAP Kinase Kinase Kinase 3
1
2000
4
0.010
Why?
Fas-Associated Death Domain Protein
1
2000
9
0.010
Why?
Caspase 8
1
2000
48
0.010
Why?
Caspase 9
1
2000
56
0.010
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2000
43
0.010
Why?
COS Cells
1
2000
185
0.010
Why?
Phosphatidylinositol 3-Kinases
1
2002
359
0.010
Why?
Antigen-Presenting Cells
1
2000
150
0.010
Why?
Caspase Inhibitors
1
2000
83
0.010
Why?
Oxidants
1
2000
109
0.010
Why?
Proto-Oncogene Proteins c-akt
1
2002
431
0.010
Why?
Molecular Sequence Data
1
2005
2832
0.010
Why?
Apoptosis Regulatory Proteins
1
2000
182
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2008
1565
0.010
Why?
Hydrogen Peroxide
1
2000
318
0.010
Why?
Mitosis
1
1999
180
0.010
Why?
Epithelial Cells
1
2003
1065
0.010
Why?
Lymphocyte Activation
1
2000
1106
0.010
Why?
Oxidative Stress
1
2003
1269
0.010
Why?
Kidney
1
2003
1385
0.010
Why?
Garrington's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)